Research
A new UAB study will investigate the role of autoantibodies and the benefit of therapeutic plasma exchange on a deadly lung disease.
A UAB study suggests a new bone boosting drug is more effective than commonly used bone loss medications in preventing fractures in women with osteoporosis.

UAB’s Civitan Rett Syndrome Clinic has been named a Center of Excellence by rettsyndrome.org, one of the nation’s leading advocacy groups.

A fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response.

These new results, led by primary author Warner Huh, M.D., strengthen the promise that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers.

This gene silencing by ubiquitinated histone is vital in normal embryo development, and it goes awry in some cancers.
UAB is joining the All of Us Research Program, an effort led by the National Institutes of Health to drive precision medicine research.
UAB researchers want to create new treatments for these banes of cardiovascular disease.
Due to the current opioid crisis, UAB Hospital has launched an Addiction Scholars Program to train health care professionals across the hospital in caring for patients with addiction issues.
Researchers have discovered the mechanism of this control, with implications for developmental biology, the immune response and cancer dysregulation.
Page 7 of 95
Back to Top